Clinical Trial

Compound Danshen Dripping Pill for Diabetic Microvascular Angina

Study acronym: MVA
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
To investigate the efficacy and safety of Compound Danshen Dripping Pill in patients with diabetic microvascular angina pectoris. Long-term follow-up of 1 year will be performed to evaluate the effect of Compound Danshen Dripping Pill on coronary flow reserve and adverse cardiovascular events in patients with coronary microvascular disease.
Trial Details
NCT Number NCT06727890
Lead Sponsor Qilu Hospital of Shandong University
Conditions Diabetic Microvascular Angina
Enrollment 162 participants
Start Date 2025-01-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2024-12-11